103 related articles for article (PubMed ID: 29669754)
1. Ectopic Lck expression in CLL demarcates intratumoral subpopulations with aberrant B-cell receptor signaling.
Theofani E; Alexis S; Costeas P; Andriopoulos C; Feleskoura G; Zikos P; Aktypi A; Spyridonidis A; Nika K
Blood Adv; 2018 Apr; 2(8):877-882. PubMed ID: 29669754
[TBL] [Abstract][Full Text] [Related]
2. Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome.
Till KJ; Allen JC; Talab F; Lin K; Allsup D; Cawkwell L; Bentley A; Ringshausen I; Duckworth AD; Pettitt AR; Kalakonda N; Slupsky JR
Sci Rep; 2017 Dec; 7(1):16784. PubMed ID: 29196709
[TBL] [Abstract][Full Text] [Related]
3. Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells.
Majolini MB; D'Elios MM; Galieni P; Boncristiano M; Lauria F; Del Prete G; Telford JL; Baldari CT
Blood; 1998 May; 91(9):3390-6. PubMed ID: 9558397
[TBL] [Abstract][Full Text] [Related]
4. LCK is an important mediator of B-cell receptor signaling in chronic lymphocytic leukemia cells.
Talab F; Allen JC; Thompson V; Lin K; Slupsky JR
Mol Cancer Res; 2013 May; 11(5):541-54. PubMed ID: 23505068
[TBL] [Abstract][Full Text] [Related]
5. Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.
Märklin M; Fuchs AR; Tandler C; Heitmann JS; Salih HR; Kauer J; Quintanilla-Martinez L; Wirths S; Kopp HG; Müller MR
Front Immunol; 2020; 11():1995. PubMed ID: 32983140
[TBL] [Abstract][Full Text] [Related]
6. Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck.
Dal Porto JM; Burke K; Cambier JC
Immunity; 2004 Sep; 21(3):443-53. PubMed ID: 15357954
[TBL] [Abstract][Full Text] [Related]
7. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
[TBL] [Abstract][Full Text] [Related]
8. B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigen.
Mulligan SP; Dao LP; Francis SE; Thomas ME; Gibson J; Cole-Sinclair MF; Wolf M
Br J Haematol; 1998 Oct; 103(1):157-62. PubMed ID: 9792303
[TBL] [Abstract][Full Text] [Related]
9. Lenalidomide Induces Interleukin-21 Production by T Cells and Enhances IL21-Mediated Cytotoxicity in Chronic Lymphocytic Leukemia B Cells.
Browning RL; Byrd WH; Gupta N; Jones J; Mo X; Hertlein E; Yu L; Muthusamy N; Byrd JC
Cancer Immunol Res; 2016 Aug; 4(8):698-707. PubMed ID: 27287425
[TBL] [Abstract][Full Text] [Related]
10. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.
Robak T; Robak P
Int Rev Immunol; 2013 Aug; 32(4):358-76. PubMed ID: 23617253
[TBL] [Abstract][Full Text] [Related]
11. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
12. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
[TBL] [Abstract][Full Text] [Related]
13. Role of spleen tyrosine kinase in the pathogenesis of chronic lymphocytic leukemia.
Feng G; Wang X
Leuk Lymphoma; 2014 Dec; 55(12):2699-705. PubMed ID: 24547708
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.
Huber S; Oelsner M; Decker T; zum Büschenfelde CM; Wagner M; Lutzny G; Kuhnt T; Schmidt B; Oostendorp RA; Peschel C; Ringshausen I
Leukemia; 2011 May; 25(5):838-47. PubMed ID: 21293487
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
Efremov DG; Gobessi S; Longo PG
Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
[TBL] [Abstract][Full Text] [Related]
16. Normal B-1 cell development but defective BCR signaling in Lck-/- mice.
Ulivieri C; Valensin S; Majolini MB; Matthews RJ; Baldari CT
Eur J Immunol; 2003 Feb; 33(2):441-5. PubMed ID: 12645942
[TBL] [Abstract][Full Text] [Related]
17. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
Maddocks K; Jones JA
Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways.
Cochrane R; Clark RB; Huang CK; Cone RE
J Interferon Cytokine Res; 2001 Oct; 21(10):797-807. PubMed ID: 11710991
[TBL] [Abstract][Full Text] [Related]
19. TCR-induced T cell activation leads to simultaneous phosphorylation at Y505 and Y394 of p56(lck) residues.
Nyakeriga AM; Garg H; Joshi A
Cytometry A; 2012 Sep; 81(9):797-805. PubMed ID: 22674786
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
